Molecular Biology of Polycythemia and Thrombocytosis
NCT00722527 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-03-09
Summary
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Conditions
- Polycythemia
- Thrombocytosis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Josef T. Prchal, MD · University of Utah
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2028-07-31
- Completion
- 2028-07-31
Countries
- United States
Study Locations
More Related Trials
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING
-
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
NCT03572036 ·Status: COMPLETED
-
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307 ·Status: COMPLETED
-
Inflammation, Platelets and Sickle Cell Disease
NCT05646888 ·Status: ACTIVE_NOT_RECRUITING
-
Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department
NCT02386657 ·Status: COMPLETED
-
Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
NCT01888614 ·Status: WITHDRAWN
-
The Impact of Oxidative Stress on Erythrocyte Biology
NCT04028700 ·Status: TERMINATED ·Phase: PHASE2
-
Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
NCT05440838 ·Status: RECRUITING
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA
-
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
NCT06944067 ·Status: RECRUITING
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease
NCT03629678 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients
NCT01736657 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension
NCT00850369 ·Status: WITHDRAWN ·Phase: PHASE2
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 ·Status: TERMINATED
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
Induction of Stable Chimerism for Sickle Cell Anemia
NCT00029393 ·Status: COMPLETED ·Phase: PHASE2
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Long Term Effects of Erythrocyte Lysis
NCT00842621 ·Status: COMPLETED
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
NCT00047996 ·Status: ENROLLING_BY_INVITATION
-
Living With Sickle Cell Disease in the COVID-19 Pandemic
NCT04417673 ·Status: COMPLETED
-
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
NCT05214105 ·Status: RECRUITING